盈康生命(300143.SZ):擬與海爾保理開展無追索權的應收賬款保理業務
格隆匯12月6日丨盈康生命(300143.SZ)公佈,因業務發展需要,公司全資子公司瑪西普醫學科技發展(深圳)有限公司(“瑪西普”)擬與海爾金融保理(重慶)有限公司(“海爾保理”)開展無追索權的應收賬款保理業務,自董事會審議通過之日起一年內保理融資金額不超過人民幣2億元,擬開展的保理業務融資成本由應收賬款債務人承擔,子公司瑪西普不予承擔。具體保理業務內容以單項保理合同約定為準,公司董事會授權公司管理層負責上述事項的具體實施,並簽署保理業務事項有關的合同、協議等各項文件。
海爾保理為公司實際控制人海爾集團公司控制的企業。根據《深圳證券交易所創業板股票上市規則》的規定,海爾保理為公司關聯法人,此次交易構成關聯交易。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.